Entering the golden age for antibody-drug conjugates in gynecologic cancer

Oncoscience. 2024 May 20:11:51-52. doi: 10.18632/oncoscience.604. eCollection 2024.

Authors

Michelle Greenman¹, Blair McNamara¹, Levent Mutlu¹, Alessandro D Santin¹

Affiliation

¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.

No abstract available

Keywords: antibody-drug conjugates; gynecologic malignancies; precision medicine.

Publication types

Editorial

Grants and funding